BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36856920)

  • 1. Purinergic P2X7R as a potential target for pancreatic cancer.
    Yu Q; Wang X; Li X; Bai X; Zhao R; Peng X
    Clin Transl Oncol; 2023 Aug; 25(8):2297-2305. PubMed ID: 36856920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.
    Magni L; Bouazzi R; Heredero Olmedilla H; Petersen PSS; Tozzi M; Novak I
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the purinergic ligand-gated ion channel 7 receptor in common digestive system cancers.
    Wang X; Yu Q; Bai X; Li X; Sun Y; Peng X; Zhao R
    Eur J Cancer Prev; 2024 May; 33(3):271-281. PubMed ID: 37942897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
    Giannuzzo A; Saccomano M; Napp J; Ellegaard M; Alves F; Novak I
    Int J Cancer; 2016 Dec; 139(11):2540-52. PubMed ID: 27513892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the relationship between P2X7R and colorectal cancer.
    Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
    Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATP-gated P2X7 receptor as a potential target for prostate cancer.
    Qiao C; Tang Y; Li Q; Zhu X; Peng X; Zhao R
    Hum Cell; 2022 Sep; 35(5):1346-1354. PubMed ID: 35657562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer.
    Li Q; Zhu X; Song W; Peng X; Zhao R
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2731-2741. PubMed ID: 32892231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
    Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
    Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of hepatic stellate cell activation by extracellular ATP is dependent on P2X7R-mediated NLRP3 inflammasome activation.
    Jiang S; Zhang Y; Zheng JH; Li X; Yao YL; Wu YL; Song SZ; Sun P; Nan JX; Lian LH
    Pharmacol Res; 2017 Mar; 117():82-93. PubMed ID: 27940204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP enhances radiation-induced brain injury through microglial activation and paracrine signaling via P2X7 receptor.
    Xu P; Xu Y; Hu B; Wang J; Pan R; Murugan M; Wu LJ; Tang Y
    Brain Behav Immun; 2015 Nov; 50():87-100. PubMed ID: 26122280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ATP-P2X
    Wang-Fang J; Chun-Jie J; Fei G; Jia-Hui L; Ming L
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jul; 29(4):526-529. PubMed ID: 29508600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [P2X7R promotes migration and invasion of Lewis lung cancer cells by activating the AKT signaling pathway].
    Tang Y; Zhao R; Qiao C; Li X; Bai X; Peng X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1495-1502. PubMed ID: 36329583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purinergic P2X7 receptor as a potential therapeutic target in depression.
    Qi W; Jin X; Guan W
    Biochem Pharmacol; 2024 Jan; 219():115959. PubMed ID: 38052270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
    Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
    Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.
    Martínez-Cuesta MÁ; Blanch-Ruiz MA; Ortega-Luna R; Sánchez-López A; Álvarez Á
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of purinergic P2X
    McLarnon JG
    Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P2X7 receptor in prognosis and metastasis of colorectal cancer.
    Zhang Y; Ding J; Wang L
    Adv Med Sci; 2019 Sep; 64(2):388-394. PubMed ID: 31276917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of antigen receptor-dependent Ca(2+) signals and NF-AT activation by P2X7 receptors in human B lymphocytes.
    Pippel A; Beßler B; Klapperstück M; Markwardt F
    Cell Calcium; 2015 Apr; 57(4):275-89. PubMed ID: 25678443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.